You just read:

Brainstorm Reports on Successful End of Phase 2 Meeting with FDA, Upcoming Phase 3 Trial and Planned Application for Hospital Exemption for NurOwn®

News provided by

BrainStorm Cell Therapeutics Inc.

Dec 19, 2016, 02:06 ET